IN8BIO, Inc.
INAB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001740279
No open-market purchases or sales by IN8BIO, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $5.35M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in IN8BIO, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +2 vs. Q1 2026
- Shares held
- 3.79M
- +37.0K (+1.0%) vs. Q1 2026
- Total value
- $5.35M
- −$209.3K (−3.8%) vs. Q1 2026
- New holders
- 3
- 5 more added
- Sold out
- 1
- 3 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INAB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $5.35M |
| Q1 2026 | 19 | $5.55M |
| Q4 2025 | 22 | $7.45M |
| Q3 2025 | 19 | $2.13M |
| Q2 2025 | 12 | $1.83M |
| Q1 2025 | 28 | $3.60M |
| Q4 2024 | 26 | $7.72M |
| Q3 2024 | 26 | $2.06M |
| Q2 2024 | 26 | $6.77M |
| Q1 2024 | 32 | $10.2M |
| Q4 2023 | 30 | $11.4M |
| Q3 2023 | 21 | $2.58M |
| Q2 2023 | 22 | $3.59M |
| Q1 2023 | 17 | $1.78M |
| Q4 2022 | 16 | $2.79M |
| Q3 2022 | 17 | $2.42M |
| Q2 2022 | 15 | $5.50M |
| Q1 2022 | 14 | $7.02M |
| Q4 2021 | 14 | $7.80M |
| Q3 2021 | 13 | $12.2M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding IN8BIO, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 1 | $1 | 0.00% | −479−99.8% | Reduced |
| Barclays PLC | 28 | $39 | 0.00% | +28 | New |
| Rockefeller Capital Management L.P. | 83 | $117 | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 84 | $118 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 768 | $1.04K | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 2,785 | $3.93K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,738 | $5.27K | 0.00% | +2,473+195.5% | Added |
| Renaissance Technologies LLC | 12,100 | $17.1K | 0.00% | +12,100 | New |
| Northern Trust Corp | 21,734 | $30.6K | 0.00% | +1,294+6.3% | Added |
| Texas Capital Bank Wealth Management Services Inc | 24,406 | $34.4K | 0.00% | +656+2.8% | Added |
| Captrust Financial Advisors | 33,295 | $46.9K | 0.00% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 43,570 | $62.0K | 0.00% | 00.0% | Unchanged |
| Oppenheimer & Co Inc | 63,042 | $88.9K | 0.00% | +39,009+162.3% | Added |
| Citadel Advisors LLC | 63,055 | $88.9K | 0.00% | +63,055 | New |
| Geode Capital Management, LLC | 72,550 | $102.3K | 0.00% | −13,689−15.9% | Reduced |
| BIOS Capital Management, LP | 80,957 | $114.1K | 0.27% | −86,848−51.8% | Reduced |
| Vanguard Capital Management LLC | 88,865 | $126.5K | 0.00% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 695,287 | $980.4K | 0.75% | +31,875+4.8% | Added |
| 683 Capital Management, LLC | 724,637 | $1.02M | 0.09% | 00.0% | Unchanged |
| Franklin Resources Inc | 914,531 | $1.29M | 0.00% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 944,319 | $1.33M | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 0 | $0 | 0.00% | −12,433−100.0% | Sold out |